VistaGen Therapeutics Inc
NASDAQ:VTGN 4:00:00 PM EDT
Equity Financing / Related
Vistagen Therapeutics Announces Pricing Of Underwritten Public Offering
Published: 12/18/2020 12:59 GMT
VistaGen Therapeutics Inc (VTGN) - Vistagen Therapeutics Announces Pricing of Underwritten Public Offering.
Vistagen Therapeutics Inc - Pricing Offering of 63 Million Shares at $0.92/share and 2 Million Shares of Series D Convertible Preferred Stock at $21.16/share.
Vistagen Therapeutics Inc - Gross Proceeds From Offering Are Expected to Be $100 Million.
Vistagen Therapeutics Inc - Pricing Offering of 63 Million Shares at $0.92/share and 2 Million Shares of Series D Convertible Preferred Stock at $21.16/share.
Vistagen Therapeutics Inc - Gross Proceeds From Offering Are Expected to Be $100 Million.